Postmarketing analysis of medicines: Methodology and value of the Spanish case-control study and surveillance system in preventing birth defects

Drug Safety

Volumn 30, Issue 4, 2007, Pages 307-316

  Martínez Frías, María Luisa ^a,b  

^a SCHOOL OF MEDICINE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PARACETAMOL; SEX HORMONE; TOPIRAMATE; VALPROIC ACID;

BIRTH DEFECT; CHROMOSOME ABERRATION; CONGENITAL MALFORMATION; DRUG INFORMATION; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EBSTEIN ANOMALY; HEALTH PROGRAM; HEREDITY; HUMAN; HYPOSPADIAS; PILONIDAL SINUS; POSTMARKETING SURVEILLANCE; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SYNDACTYLY; TRISOMY;

EID: 34247193099     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200730040-00003     Document Type: Review

References (33)

1. Lenz W. Thalidomide and congenital anomalies. Lancet 1962 Jan 6; 1: 45
2. EUROCAT Working Group (2002). Report 8: surveillance of congenital anomalies in Europe 1980-1999 [online]. Available from URL: http://www.eurocat. ulster.ac.uk/ [Accessed 2007 Mar 6]
3. ICBDMS (International Clearinghouse for Birth Defects Monitoring Systems) papers and reports: annual report 2004 with data for 2002 [online]. Available from URL: http://www.icbd.org/document/AR2004/index.htm [Accessed 2007 Mar 6]
4. Wide K, Winbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 2004 Feb; 93 (2): 174-6
5. Czeizel AE, Metneki J, Kazy Z, et al. A population-based case-control study of oral griseofulvin treatment during pregnancy. Acta Obstet Gynecol Scand. 2004 Sep; 83 (9): 827-31
6. Congenital malformations worldwide: a report from the International Clearinghouse for Birth Defects Monitoring Systems. New York: Elsevier Science Publishers, 1991
7. Kallen B, Castilla EE, Robert E, et al. An international case-control study on hypospadias: the problem with variability and the beauty of diversity. Eur J Epidemiol 1992 Mar; 8 (2): 256-63
8. Little PF. Structure and function of the human genome. Genome Res 2005 Dec; 15 (12): 1759-66
9. Engel LW. The Human Genome Project. History, goals, and progress to date. Arch Pathol Lab Med 1993 May; 117 (5): 459-65
10. Prieto L, Martinez-Frias ML. Case-control studies using only malformed infants: are we interpreting the results correctly? Teratology 1999 Jul; 60 (1): 1-2
11. Prieto L, Martinez-Frias ML. Case-control studies using only malformed infants who were prenatally exposed to drugs: what do the results mean? Teratology 2000 Jul; 62 (1): 5-9
12. Prieto L, Martinez-Frias ML. Response to 'what kind of controls to use in case control studies of malformed infants: recall bias versus "teratogen nonspecificity" bias [letter]. Teratology 2000 Dec; 62 (6): 372
13. Hook EB. What kind of controls to use in case control studies of malformed infants: recall bias versus "teratogen nonspecificity" bias. Teratology 2000 May; 61 (5): 325-6
14. Shapiro L, Pastuszak A, Curto G, et al. Safety of first trimester exposure to topical tretinoin: prospective cohort study. Lancet 1997 Oct 18; 350 (9085): 1143-4
15. Martinez-Frias ML, Rodriguez-Pinilla E. First-trimester exposure to topical tretinoin: its safety is not warranted [letter]. Teratology 1999 Jul; 60 (1): 5
16. Mitchell A. Systematic identification of drugs that causes birth defects: a new opportunity. N Engl J Med 2003; 349: 2556-9
17. Martinez-Frias ML, Frias JL. VACTERL as primary, polytopic developmental field defects. Am J Med Genet 1999; 83: 13-6
18. Martinez-Frias ML. Epidemiological analysis of the association of congenital diaphragmatic hernia with upper-limb deficiencies: a primary polytopic developmental field defect. Am J Med Genet 1996; 62: 68-70
19. Martinez-Frias ML, Bermejo E, Rodriguez-Pinilla E. Anal atresia, vertebral, genital, and urinary tract anomalies: a primary polytopic developmental field defect identified through an epidemiological analysis of associations. Am J Med Genet 2000; 95: 169-73
20. Martinez-Frias ML, Bermejo E, Rodriguez-Pinilla E, et al. Exstrophy of the cloaca and exstrophy of the bladder: two different expressions of a primary developmental field defect. Am J Med Genet 2001; 99: 261-9
21. Martinez-Frias ML. Segmentation anomalies of the vertebras and ribs: one expression of the primary developmental field. Am J Med Genet A 2004; 128: 127-31
22. Martinez-Frias ML, Bermejo E, Rodriguez-Pinilla E, et al. Secular evolution and evolution according to autonomous communities of the frequency of fertility treatments, multiple deliveries and cesarean sections in Spain [in Spanish]. Med Clin (Barc) 2005 Feb 5; 124 (4): 132-9
23. Rimm AA, Katayama AC, Diaz M, et al. A meta-analysis of controlled studies comparing major malformation rates in IVF and ICSI infants with naturally conceived children. J Assist Reprod Genet 2004; 21: 437-43
24. Bonduelle M, Wennerholm UB, Loft A, et al. A multi-center cohort study of the physical health of 5-years-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception. Hum Reprod 2005; 20: 413-9
25. Rodríguez-Pinilla E, Salvador J, García Alonso F, et al. Relationship between benzodiacepine ingestion during pregnancy and oral clefts in the newborn: a ces-control study. Med Clin (Barc) 1986; 87: 741-3
26. Martinez-Frias ML, Rodriguez-Pinilla E, Bermejo E, et al. Prenatal exposure to sex hormones: a case-control study. Teratology 1998; 57: 8-12
27. Martinez-Frias ML, Salvador J. Epidemiological aspects of prenatal exposure to high doses of vitamin A in Spain. Eur J Epidemiol 1990; 6: 118-23
28. Martinez-Frias ML, Rodriguez-Pinilla E, Prieto L. Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology 1997; 56: 241-3
29. Rodriguez-Pinilla E, Martinez-Frias ML. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 1998; 58: 2-5
30. Martinez-Frias ML, Rodriguez-Pinilla E. Epidemiologic analysis of prenatal exposure to cough medicines containing dextromethorphan: no evidence of human teratogenicity. Teratology 2001; 63: 38-41
31. Martinez-Frias ML. Interviewer bias and maternal bias. Teratology 1993; 47: 531-2
32. Castilla EE, Orioli IM. ECLAMC: the Latin-American collaborative study of congenital malformations. Community Genet 2004; 7: 76-94
33. Mutchinick O, Lisker R, Babinski V. The Mexican program of Registration and Epidemiologic Surveillance of External Congenital Malformations [in Spanish]. Salud Publica Mex 1988 Jan-Feb; 30: 88-100